SAN FRANCISCO Nov. 3 2016 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the third quarter ended September 30 2016. Cash and investments in marketable securities at September 30 2016 were $253.5 million as compared...
↧